PRTC Stock Analysis: Buy, Sell, or Hold?
PRTC - PureTech Health plc American Depositary Shares
$18.69
-0.42 (-2.20%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Apr 30, 2026
Get Alerted When PRTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PRTC shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: PRTC shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: PRTC is currently trading at $18.69, which is considered slightly high relative to its 30-day fair value range of $17.11 to $18.92.
Technical Outlook: Technically, PRTC is showing sideways momentum. Immediate support is located at $17.31, while resistance sits at $19.92.
Market Sentiment: PRTC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $46.00 (+146.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PRTC is showing sideways momentum. Immediate support is located at $17.31, while resistance sits at $19.92.
Market Sentiment: PRTC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $46.00 (+146.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$17.11 -
$18.92
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 146.1% below Wall St target ($46.00)
Fair Price Analysis
30-Day Fair Range
$17.11 -
$18.92
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$17.31
Resistance Level
$19.92
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-8.13
Wall Street Target
$46.00
(+146.1%)
Revenue Growth (YoY)
542.7%
Earnings Growth (YoY)
61.5%
Profit Margin
793.0%
Last updated: February 01, 2026 6:11 PM ET
Data refreshes hourly during market hours. Next update: 7:11 PM
Data refreshes hourly during market hours. Next update: 7:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 60 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$42 | 53 HOLD |
